Open call for tenders
Kasvajavastased ravimid, immunosupressandid, oftalmoloogias kasutatavad ravimid, hingamisteede obstruktiivsete haiguste raviks kasutatavad ravimid, migreenivastased ravimid
Pharmaceutical products · for sihtasutus Põhja-Eesti Regionaalhaigla · Estonia · published in Estonian
What the buyer wants
Kasvajavastaste ravimite, immunosupressantide, oftalmoloogias kasutatavate ravimite, hingamisteede obstruktiivsete haiguste raviks kasutatavate ravimite, migreenivastaste ravimite ostmine / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
30 lots
- Panitumumab
- Gemtuzumabosogamtsiin
- Brentuksimabvedotiin
- Pertuzumab
- Trastuzumabemtansiin
- Obinutuzumab
- Nivolumab
- Pembrolizumab
- Blinatumomab
- Daratumumab
- Durvalumab
- Atezolisumab
- Tsemiplimab
- Sugemalimab
- Ipilimumab
- Mogamulizumab
- Enfortumabvedotiin
- Teklistamab
- Karfilsomiib
- Iksasomiib
- Pertuzumab + trastuzumab
- Küüliku anti-T-lümfotsüütne immuunoglobuliin
- Vedolizumab
- Golimumab
- Anakinra
- Ustekinumab
- Sekukinumab
- Sarilumab
- Belimumab
- Anifrolumab
Companies that won similar tenders
Companies that won public tenders in the same category (Pharmaceutical products) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.
- pharmos.cz · Czechia393 wins · last 2 Nov 2026
- Novartis · Czechia10 wins · last 2 Nov 2026
- Janssen-Cilag · United Kingdom6 wins · last 16 May 2025
- Substipharm · France4 wins · last 13 Aug 2025
- Panpharma · France4 wins · last 16 May 2025
- Grindeks Kalceks Suomi · Finland3 wins · last 8 Sep 2026
- lekarnalemon.cz · Czechia3 wins · last 8 Jul 2026
- Provepharm · France3 wins · last 16 May 2025
- Lso Medical · France2 wins · last 13 Mar 2025
- Aspironix · Czechia1 win · last 28 May 2026
- lekarna.cz · Czechia1 win · last 29 Sep 2025
- nemcb.cz · Czechia1 win · last 11 Sep 2025
and 3 more.